ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases

Debu Tripathy, Sara M. Tolaney, Andrew D. Seidman, Carey K. Anders, Nuhad Ibrahim, Hope S. Rugo, Chris Twelves, Veronique Dieras, Volkmar Müller, Mary Tagliaferri, Alison L. Hannah, Javier Cortés

Research output: Contribution to journal › Article › peer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'ATTAIN: Phase III study of etirinotecan pegol versus treatment of physician's choice in patients with metastatic breast cancer and brain metastases'. Together they form a unique fingerprint.

Medicine & Life Sciences